Phys.org: Phys.org news tagged with: lucentishttp://phys.org/
en-usPhys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.http://cdn.phys.org/tmpl/v4/img/phys.org.140.pngPhys.orghttp://phys.org/
FDA panel unanimously backs Regeneron eye drug(AP) -- A panel of federal health experts voted unanimously in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market.http://phys.org/news227540352.html
Medicine & HealthFri, 17 Jun 2011 14:39:29 ESTnews227540352Researchers find no difference in drugs for macular degenerationResearchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD). The study, which appears currently on-line in Eye, is believed to be the first study to describe one-year outcomes of a prospective, double-masked, randomized clinical trial directly comparing bevacizumab to ranibizuamab. Last October, these same researchers published early, six month outcomes of the same study, which also failed to show a difference in efficacy between these two drugs for treating AMD.http://phys.org/news205130954.html
Medicine & HealthFri, 01 Oct 2010 05:49:58 ESTnews205130954